Associated Papers
A phase 1/2 open label nonrandomized clinical trial of intravenous 2-hydroxypropyl-β-cyclodextrin for acute liver disease in infants with Niemann-Pick C1.
Reynolds M et al.
Molecular Genetics and Metabolism Reports, 2021
Select a paper to view details